# A Study of Azidothymidine in HIV-Infected Children

> **NCT00000982** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 75 (—)

## Conditions studied

- Encephalopathies
- HIV Infections

## Interventions

- **DRUG:** Zidovudine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00000982
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 1996-09
- **Final completion:** —
- **Target enrollment:** 75 (—)
- **Last updated:** 2011-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000982, "A Study of Azidothymidine in HIV-Infected Children". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00000982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*